THE ROLE OF THE SIGNALING SYSTEM OF INSULIN-LIKE GROWTH FACTORS IN THE PROGRESS OF PAPILLAR THYROID CANCER

Hershman JM. The Increased Incidence of Thyroid Cancer Is Worldwide. Clinical Thyroidolog. 2017; 29(1): 11-12. doi. https://doi.org/10.1089/ct.2017;29.11 -12

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2): 115-132. doi. 10.3322/caac.21338

Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, et al. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer. 2014; 120(9): 1345-1352. doi: 10.1002/СПСГ.28562

Liu Y, Su L, Xiao H. Review of Factors Related to the Thyroid Cancer Epidemic. Int J Endocrinol. 2017; 2017: 5308635. doi: 0.1155/2017/5308635

Lortet-Tieulent J, Franceschi S, Dal Maso L, Vaccarella S. Thyroid cancer "epidemic" also occurs in low- and middle-income countries. Int J Cancer. 2019; 144(9): 2082-2087. doi: 10.1002/ijc.31884

Hershman JM. Thyroid Cancer Incidence and Mortality Are Increasing. Clinical Thyroidology. 2017; 29: 221-223.

Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, Busco S, et al. The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998-2012. Eur J Cancer. 2018; 94: 6-15. doi: 10.1016/j.ejca.2018.01.083

The main indicators of the endocrinology service of Ukraine in 2015. Endocrinology. 2016; 21(1): 1-38.

Chukur OO. Dynamics of morbidity and expansion of pathology of the thyroid gland among adult population of Ukraine. Bulletin of social hygiene and health care organization of Ukraine. 2019; 4: 19-25. doi: 0.11603/1681- 2786.2018.4.1002012

Bowers LW, Rossi EL, O’Flanagan CH, deGraffenried LA, Bursting SD. The role of the insulin/igf system in cancer: Lessons learned from clinical trials and the energy balance-cancer link. Front. Endocrinol (Lausanne). 2015; 6: 77. doi: 10.3389/fendo.2015.00077

Baxter, R.C. Igf binding proteins in cancer: Mechanistic and clinical insights. Flat. Rev. Cancer. 2014, 14, 329-341. doi: 10.3389/fendo.2015.00077

Weroha SJ, Haluska P. The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am. 2012; 41(2): 335-vi. doi: 10.1016/j.ecl.2012.04.014

CiampoIillo A, De Tullio C, Giorgino F. The igf-i/igf-i receptor pathway: Implications in the pathophysiology of thyroid cancer. Curr. Med. Chem. 2005; 12: 2881-2891. doi: 10.2174/092986705774454715

Vigneri PG, Tirro E, Pennisi MS., Massimino M., Stella S., Romano C., Manzella L. The insulin/igf system in colorectal cancer development and resistance to therapy. Front. Oncol. 2015; 5:230. doi: 10.3389/fonc.2015.00230

Simpson A, Petnga W, Macaulay VM, Weyer-Czemilofsky U, Bogenrieder T. Insulin-like growth factor (igf) pathway targeting in cancer: Role of the igf axis and opportunities for future combination studies. Target. Oncol. 2017; 12:571-597. doi: 10.1007/sl 1523-017-0514-5

Bowers LW, Rossi EL, O'Flanagan CH, deGraffenried LA, Bursting SD. The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Front Endocrinol (Lausanne). 2015; 6: 77. doi: 10.3389/fendo.2015.00077

Zhang M, Liu J, Li M, Zhang S, L u Y, Liang Y, Zhao K, Li Y. Insulin-like growth factor 1/insulin-like growth factor 1 receptor signaling protects against cell apoptosis through the PI3K/AKT pathway in glioblastoma cells. ExpTherMed. 2018; 16(2): 1477-1482. doi: 10.3892/etm.2018.6336

Vella V, Malaguamera R. The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives. Int J Mol Sci. 2018; 19(12): 3814. doi: 10.3390/ijms 19123814

Long-term experience of Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine in the treatment of thyroid cancer / H.I. Tkachenko, L.Ya. Vasyliev, O.M. Astapieva et al. //